Ozempic (semaglutide) is a prescription medication primarily used to manage type 2 diabetes. It helps control blood sugar levels and may also aid in weight loss.
No, Ozempic is not currently approved by the FDA for the treatment of prediabetes. It is specifically approved for type 2 diabetes management.
While Ozempic is not officially approved for prediabetes, some doctors may prescribe it off-label for patients at high risk of developing type 2 diabetes. This decision depends on individual health factors and should be made by a healthcare professional.
For prediabetes, the primary focus is on lifestyle changes to prevent progression to type 2 diabetes. These include:
In some cases, medications like metformin may be prescribed to reduce the risk of developing diabetes.
If you have prediabetes, consult your doctor to determine the best course of action. They will assess your individual risk factors and decide whether Ozempic or other treatments are appropriate for you.